134 related articles for article (PubMed ID: 17224647)
1. Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer.
Zhou Y; Ran J; Tang C; Wu J; Honghua L; Xingwen L; Ning C; Qiao L
Cancer Biol Ther; 2007 Feb; 6(2):269-75. PubMed ID: 17224647
[TBL] [Abstract][Full Text] [Related]
2. [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
Ran JT; Zhou YN; Tang CW; Lu JR; Wu J; Lu H; Yang GD
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):448-51. PubMed ID: 19024521
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
[TBL] [Abstract][Full Text] [Related]
7. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines.
Sitarz R; Leguit RJ; de Leng WW; Morsink FH; Polkowski WP; Maciejewski R; Offerhaus GJ; Milne AN
Cell Oncol; 2009; 31(6):475-85. PubMed ID: 19940363
[TBL] [Abstract][Full Text] [Related]
9. Preoperative growth inhibition of human gastric adenocarcinoma treated with a combination of celecoxib and octreotide.
Huang MT; Chen ZX; Wei B; Zhang B; Wang CH; Huang MH; Liu R; Tang CW
Acta Pharmacol Sin; 2007 Nov; 28(11):1842-50. PubMed ID: 17959037
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
12. Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: implications on chemoprevention.
Yu J; Tang BD; Leung WK; To KF; Bai AH; Zeng ZR; Ma PK; Go MY; Hu PJ; Sung JJ
World J Gastroenterol; 2005 Jan; 11(1):41-5. PubMed ID: 15609394
[TBL] [Abstract][Full Text] [Related]
13. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma.
Shi H; Xu JM; Hu NZ; Xie HJ
World J Gastroenterol; 2003 Jul; 9(7):1421-6. PubMed ID: 12854133
[TBL] [Abstract][Full Text] [Related]
17. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.
Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H
Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378
[TBL] [Abstract][Full Text] [Related]
18. [Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
Ran JT; Zhou YN; Tang CW; Li HH; Li XW; Lu H
Ai Zheng; 2009 Apr; 28(4):361-5. PubMed ID: 19622294
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib can induce vascular endothelial growth factor expression and tumor angiogenesis.
Xu K; Gao H; Shu HK
Mol Cancer Ther; 2011 Jan; 10(1):138-47. PubMed ID: 21220497
[TBL] [Abstract][Full Text] [Related]
20. Impact of celecoxib on soluble intercellular adhesion molecule-1 and soluble e-cadherin concentrations in human colon cancer cell line cultures exposed to phytic acid and TNF-alpha.
Parfiniewicz B; Pendzich J; Gruchlik A; Hollek A; Weglarz L
Acta Pol Pharm; 2012; 69(6):1283-90. PubMed ID: 23285691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
